Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients

Not Applicable

Completed

• Conditions: Older Patients; Medication Review; Cross-sectional Communication
• Interventions: Behavioral: Medication review

• Registration Number: NCT03369652
• Lead Sponsor: Odense University Hospital

Brief Summary

In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology.

The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-11-21
• Study Start: 2017-11-24
• Study First Submitted QC: 2017-12-06
• Study First Posted: 2017-12-12
• Primary Completion: 2018-11-01
• Study Completion: 2018-11-30
• Status Verified: 2019-03
• Last Update Submitted: 2019-03-18
• Last Update Posted: 2019-03-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 232

Inclusion Criteria

* 5 drugs or more

Read More

Exclusion Criteria

• Terminal illness
• Not able to speak and understand Danish

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	Medication review	Medication history by pharmaconomist. Medication review by pharmacist, patient interview, and conference with physician in hospital, telephone contact to general practitioner after discharge, medication report sent to primary care.

Primary Outcome Measures

Name	Time	Method
Parts of the intervention completed	Day 1 after discharge	In the intervention Group only, it is measured, how many of the elements of the intervention the patient actually have received
Changes in number of medications	At admission and at discharge	Increase or decrease in number of medications from admission to discharge
Changes in the Electronic Medication Profile (FMK)	14 days after discharge	How many changes have been Applied to the Electronic Medication Profile

Secondary Outcome Measures

Name	Time	Method
Changes in patient-experienced quality of life	At admission and 14 days after discharge	Measured by telephone interview using the 5-item questionnaire EQ-5D, where each question can be answered on a 5-point Likert Scale ranging from "very high degree of problems" to "very low degree of problems"
Number of readmissions	within 30 days after discharge	Data from registers
Number of visits at general practitioner	within 30 days after discharge	Data from registers
Number of emergency visits	within 30 days after discharge	Data from registers
Patient satisfaction with the discharge	14 days after discharge	Measured by telephone interview
Health care professionals satisfaction	3 months after implementation	Measured by a questionnaire

Trial Locations

Locations (2)

Svendborg Sygehus; 🇩🇰 Svendborg, Denmark

Odense University Hospital; 🇩🇰 Odense, Denmark